JP2013518124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518124A5 JP2013518124A5 JP2012551302A JP2012551302A JP2013518124A5 JP 2013518124 A5 JP2013518124 A5 JP 2013518124A5 JP 2012551302 A JP2012551302 A JP 2012551302A JP 2012551302 A JP2012551302 A JP 2012551302A JP 2013518124 A5 JP2013518124 A5 JP 2013518124A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- administered
- medicament
- day
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29964310P | 2010-01-29 | 2010-01-29 | |
| US61/299,643 | 2010-01-29 | ||
| US30850610P | 2010-02-26 | 2010-02-26 | |
| US61/308,506 | 2010-02-26 | ||
| US30911710P | 2010-03-01 | 2010-03-01 | |
| US61/309,117 | 2010-03-01 | ||
| US32439510P | 2010-04-15 | 2010-04-15 | |
| US61/324,395 | 2010-04-15 | ||
| PCT/US2011/022854 WO2011094489A1 (en) | 2010-01-29 | 2011-01-28 | Therapies for treating hepatitis c virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013518124A JP2013518124A (ja) | 2013-05-20 |
| JP2013518124A5 true JP2013518124A5 (enExample) | 2014-03-20 |
Family
ID=43901208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012551302A Pending JP2013518124A (ja) | 2010-01-29 | 2011-01-28 | Ｃ型肝炎ウイルス感染の処置のための治療法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20130034522A1 (enExample) |
| EP (1) | EP2528605A1 (enExample) |
| JP (1) | JP2013518124A (enExample) |
| KR (1) | KR20120139699A (enExample) |
| CN (1) | CN102844030A (enExample) |
| AU (1) | AU2011210795A1 (enExample) |
| CA (1) | CA2788348A1 (enExample) |
| IL (1) | IL220937A0 (enExample) |
| MX (1) | MX2012008652A (enExample) |
| RU (1) | RU2012136824A (enExample) |
| SG (1) | SG182589A1 (enExample) |
| TW (1) | TW201130502A (enExample) |
| WO (1) | WO2011094489A1 (enExample) |
| ZA (1) | ZA201205547B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8399615B2 (en) | 2005-08-19 | 2013-03-19 | Vertex Pharmaceuticals Incorporated | Processes and intermediates |
| WO2012006060A1 (en) * | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
| JP6012605B2 (ja) | 2010-09-22 | 2016-10-25 | アリオス バイオファーマ インク． | 置換されたヌクレオチドアナログ |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| AU2013201406B2 (en) | 2011-10-21 | 2014-10-02 | Abbvie Ireland Unlimited Company | Methods for treating HCV |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| CH707030B1 (de) | 2011-10-21 | 2015-03-13 | Abbvie Inc | Kombinationsbehandlung von DAAs zur Verwendung in der Behandlung von HCV |
| WO2013096680A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
| WO2013142159A1 (en) * | 2012-03-21 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
| WO2013142124A1 (en) | 2012-03-21 | 2013-09-26 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
| CA3022119A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2637847B2 (ja) | 1992-12-29 | 1997-08-06 | アボツト・ラボラトリーズ | レトロウィルス蛋白分解酵素を阻害する化合物 |
| IL110752A (en) | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
| US5559158A (en) | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
| IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
| US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
| CA2252465C (en) | 1996-04-23 | 2007-07-03 | Vertex Pharmaceuticals Incorporated | Urea derivatives as inhibitors of impdh enzyme |
| WO1998040381A1 (en) | 1997-03-14 | 1998-09-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of impdh enzyme |
| US20040058982A1 (en) | 1999-02-17 | 2004-03-25 | Bioavailability System, Llc | Pharmaceutical compositions |
| BR0009167A (pt) | 1999-03-19 | 2001-12-26 | Vertex Pharma | Inibidores de enzima impdh |
| AU2001268885A1 (en) | 2000-06-28 | 2002-01-08 | National Research Council Of Canada | Helicobacter dd-heptosyltransferase |
| SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
| DZ3487A1 (fr) | 2001-01-22 | 2002-07-25 | Merck Sharp & Dohme | Derives de nucleoside comme inhibiteurs de l'arn polymerase virale d'arn-dependant |
| EP1401825B1 (en) | 2001-06-11 | 2009-08-05 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| CA2369711A1 (en) | 2002-01-30 | 2003-07-30 | Boehringer Ingelheim (Canada) Ltd. | Macrocyclic peptides active against the hepatitis c virus |
| CA2369970A1 (en) | 2002-02-01 | 2003-08-01 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis c inhibitor tri-peptides |
| US6642204B2 (en) | 2002-02-01 | 2003-11-04 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor tri-peptides |
| US7091184B2 (en) | 2002-02-01 | 2006-08-15 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor tri-peptides |
| JP2006507235A (ja) | 2002-08-01 | 2006-03-02 | フアーマセツト・インコーポレイテツド | フラビウイルス科ウイルス感染治療のためのビシクロ［４．２．１］ノナン系を有する化合物 |
| CA2413705A1 (en) | 2002-12-06 | 2004-06-06 | Raul Altman | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
| US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| WO2004073599A2 (en) | 2003-02-18 | 2004-09-02 | Pfizer Inc. | Inhibitors of hepatitis c virus, compositions and treatments using the same |
| US6908901B2 (en) | 2003-03-05 | 2005-06-21 | Boehringer Ingelheim International, Gmbh | Hepatitis C inhibitor peptide analogs |
| WO2004101605A1 (en) | 2003-03-05 | 2004-11-25 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibiting compounds |
| PT1654261E (pt) | 2003-05-21 | 2008-01-18 | Boehringer Ingelheim Int | Compostos inibidores da hepatite c |
| WO2005018330A1 (en) | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
| JP2007505603A (ja) | 2003-09-12 | 2007-03-15 | ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド | プロテアーゼ活性および肝障害のための動物モデル |
| US6933760B2 (en) | 2003-09-19 | 2005-08-23 | Intel Corporation | Reference voltage generator for hysteresis circuit |
| RS20060197A (sr) | 2003-09-22 | 2008-09-29 | Boehringer Ingelheim International Gmbh., | Makrociklični peptidi koji su aktivni protiv hepatitisa c virusa |
| US7132504B2 (en) | 2003-11-12 | 2006-11-07 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| DE602005025855D1 (de) | 2004-01-21 | 2011-02-24 | Boehringer Ingelheim Pharma | Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus |
| US20050187192A1 (en) | 2004-02-20 | 2005-08-25 | Kucera Pharmaceutical Company | Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses |
| CN102911161A (zh) | 2004-02-20 | 2013-02-06 | 贝林格尔.英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
| US20050288333A1 (en) | 2004-06-08 | 2005-12-29 | Kem William R | Controlling angiogenesis with anabaseine analogs |
| TWI437990B (zh) | 2004-10-29 | 2014-05-21 | Vertex Pharma | Vx-950之醫藥用途 |
| JP5436864B2 (ja) | 2006-02-27 | 2014-03-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｖｘ−９５０を含む共結晶体およびそれを含む医薬組成物 |
| CA2646229A1 (en) | 2006-03-16 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Deuterated hepatitis c protease inhibitors |
| US20070218012A1 (en) | 2006-03-20 | 2007-09-20 | Bittorf Kevin J | Pharmaceutical Compositions |
| WO2007109604A2 (en) | 2006-03-20 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
| NZ596922A (en) * | 2006-11-15 | 2013-03-28 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of Flavivirus infections |
| MX2009006806A (es) | 2006-12-22 | 2009-08-27 | Vertex Pharma | Secado por rocio fluidizado. |
| KR20090115970A (ko) | 2007-02-27 | 2009-11-10 | 버텍스 파마슈티칼스 인코포레이티드 | 공-결정 및 그를 포함하는 제약 조성물 |
| WO2008144072A1 (en) | 2007-05-21 | 2008-11-27 | Vertex Pharmaceuticals Incorporated | Dose forms comprising vx- 950 and their dosage regimen |
| EP2170888B1 (en) * | 2007-06-29 | 2015-04-22 | Gilead Sciences, Inc. | Purine derivatives and their use as modulators of toll-like receptor 7 |
| WO2010002998A1 (en) * | 2008-07-03 | 2010-01-07 | Gilead Sciences, Inc. | 2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
-
2011
- 2011-01-28 CA CA2788348A patent/CA2788348A1/en not_active Abandoned
- 2011-01-28 MX MX2012008652A patent/MX2012008652A/es active IP Right Grant
- 2011-01-28 KR KR1020127021714A patent/KR20120139699A/ko not_active Withdrawn
- 2011-01-28 JP JP2012551302A patent/JP2013518124A/ja active Pending
- 2011-01-28 AU AU2011210795A patent/AU2011210795A1/en not_active Abandoned
- 2011-01-28 EP EP11703776A patent/EP2528605A1/en not_active Withdrawn
- 2011-01-28 WO PCT/US2011/022854 patent/WO2011094489A1/en not_active Ceased
- 2011-01-28 CN CN2011800168308A patent/CN102844030A/zh active Pending
- 2011-01-28 RU RU2012136824/15A patent/RU2012136824A/ru not_active Application Discontinuation
- 2011-01-28 TW TW100103512A patent/TW201130502A/zh unknown
- 2011-01-28 SG SG2012053120A patent/SG182589A1/en unknown
-
2012
- 2012-07-12 IL IL220937A patent/IL220937A0/en unknown
- 2012-07-23 ZA ZA2012/05547A patent/ZA201205547B/en unknown
- 2012-07-27 US US13/559,995 patent/US20130034522A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013518124A5 (enExample) | ||
| Flamm et al. | Ledipasvir/Sofosbuvir with Ribavirin for the Treatment of HCV in Patients with Decompensated Cirrhosis: Preliminary Results of a Prospective, Multicenter Study: 239 | |
| JP2014530874A5 (enExample) | ||
| JP2010525050A5 (enExample) | ||
| JP2012517478A5 (enExample) | ||
| RU2012136824A (ru) | Способы лечения вирусной инфекции гепатита с | |
| JP2006501240A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| JP2013155188A5 (enExample) | ||
| JP2012515184A5 (enExample) | ||
| RU2012148710A (ru) | Органическое соединение для применения при лечении рака печени | |
| JP2017506624A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| JP2015515985A5 (enExample) | ||
| JP2020503269A5 (enExample) | ||
| JP2017514911A5 (enExample) | ||
| NZ588655A (en) | Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin | |
| JP2016505050A5 (enExample) | ||
| JP2011500589A5 (enExample) | ||
| JP2008517991A5 (enExample) | ||
| JP2017061488A5 (enExample) | ||
| JP2011500650A5 (enExample) | ||
| RU2018144248A (ru) | Схемы дозирования вортиоксетина для быстрого появления антидепрессивного эффекта | |
| CN110891574B (zh) | 用于预防和/或治疗肝细胞癌的美格列明 |